share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R

EyePoint Pharmaceuticals | 4:持股变动声明-董事 GUYER DAVID R
美股sec公告 ·  07/16 16:28
Moomoo AI 已提取核心信息
On July 12, 2024, David R. Guyer, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a series of transactions involving the company's common stock. Guyer acquired a total of 9,775 shares through the exercise or conversion of derivative securities at prices ranging from $3.26 to $3.50 per share. Subsequently, Guyer sold 11,625 shares on the open market at a price of $10.0641 per share. Following these transactions, Guyer's direct holdings in EyePoint Pharmaceuticals decreased to 1,850 shares. The total market value of the disposed shares amounted to approximately $116,995.16.
On July 12, 2024, David R. Guyer, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a series of transactions involving the company's common stock. Guyer acquired a total of 9,775 shares through the exercise or conversion of derivative securities at prices ranging from $3.26 to $3.50 per share. Subsequently, Guyer sold 11,625 shares on the open market at a price of $10.0641 per share. Following these transactions, Guyer's direct holdings in EyePoint Pharmaceuticals decreased to 1,850 shares. The total market value of the disposed shares amounted to approximately $116,995.16.
2024年7月12日,与eyepoint pharmaceuticals有关的David R. Guyer完成了一系列公司普通股相关的交易。 Guyer通过行使或转换衍生证券,以每股3.26至3.50美元的价格购买了总计9,775股。随后,Guyer以每股10.0641美元的价格在公开市场上出售了11,625股。在这些交易后,Guyer在eyepoint pharmaceuticals的直接持股减少到了1,850股。抛售的股票的总市值约为116,995.16美元。
2024年7月12日,与eyepoint pharmaceuticals有关的David R. Guyer完成了一系列公司普通股相关的交易。 Guyer通过行使或转换衍生证券,以每股3.26至3.50美元的价格购买了总计9,775股。随后,Guyer以每股10.0641美元的价格在公开市场上出售了11,625股。在这些交易后,Guyer在eyepoint pharmaceuticals的直接持股减少到了1,850股。抛售的股票的总市值约为116,995.16美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息